🇧🇷Brazil

Perda por Vencimento de Medicamentos (Product Expiration Waste)

3 verified sources

Definition

Pharmacies in Brazil operating without automated inventory systems experience preventable waste from expired medications. Sources [1], [3], [4] emphasize FIFO/PEPS methodology and periodic inventories to prevent this, indicating it is a widespread pain point. When manual processes fail, products approach expiration without being prioritized for sale.

Key Findings

  • Financial Impact: Estimated: R$ 2,000–25,000 annually per pharmacy (2–5% of typical inventory value of R$ 100,000–500,000). Pharmacy chains with 10+ locations: R$ 20,000–250,000+ annually.
  • Frequency: Continuous; typically identified during quarterly or semi-annual inventory audits
  • Root Cause: Inadequate FIFO/PEPS enforcement; lack of real-time expiration date alerts; manual inventory reconciliation errors

Why This Matters

The Pitch: Brazilian retail pharmacies waste 2–5% of annual inventory value through expired product shrinkage. Manual inventory systems fail to enforce FIFO rotation. Automated expiration tracking eliminates this loss.

Affected Stakeholders

Pharmacy Manager, Warehouse Supervisor, Inventory Specialist

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Custo de Gestão Manual de Estoque (Manual Inventory Management Labor Cost)

Estimated: R$ 1,000–4,000 monthly per pharmacy location (20–40 hours × R$ 50–100/hour). Multi-location chains: R$ 10,000–40,000+ monthly for 10 locations.

Ruptura de Estoque e Perda de Vendas (Stock-Out-Induced Revenue Loss)

Estimated: 5–10% of monthly revenue per location. Average pharmacy daily revenue: R$ 5,000–20,000. Monthly loss: R$ 7,500–60,000 per pharmacy.

Multas ANVISA por Falha no Controle de Estoque (ANVISA Fines for Inventory Control Violations)

Estimated ANVISA fine: R$ 5,000–100,000+ per violation. Average fine for first-time inventory control violation: R$ 10,000–50,000. Repeated violations: escalation to license suspension (potentially R$ 500,000+ revenue impact annually).

Erro de Decisão de Compra por Falta de Visibilidade de Dados (Poor Purchasing Decisions Due to Data Gaps)

Estimated: 10–20% of annual inventory value tied up in excess slow-moving stock. Average pharmacy inventory: R$ 100,000–500,000. Excess working capital tied up: R$ 10,000–100,000+. Carrying cost (rent, shrinkage, deterioration): 15–25% annually = R$ 1,500–25,000 per pharmacy annually.

Multa por Violação de LGPD e Privacidade do Consumidor

R$ 8,497,500.00 (confirmed fine); potential industry exposure: R$ 50,000–R$ 3,000,000 per administrative proceeding depending on scale and intent.

Risco de Recusa de Cobertura de Plano de Saúde por Violação de Dados Sensíveis

Per-customer litigation cost: R$ 10,000–R$ 50,000; churn impact: 2–5% customer base loss annually; class action risk: R$ 5,000,000+.

Request Deep Analysis

🇧🇷 Be first to access this market's intelligence